menu
    • menu

    Company profile for Tryp Therapeutics

    NEW Drugs in Dev: 3
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tryp Therapeutics is one of the first players to help realize this promise, leading the next wave of psychedelic drug development that extends beyond mental health. We have proprietary and differentiated methods for manufacturing, formulating, dosing and administering psychedelic compounds. We have the right scientific and executive team to successfully deliver new therapies to patients.We are addressing indications with criti...
    Tryp Therapeutics is one of the first players to help realize this promise, leading the next wave of psychedelic drug development that extends beyond mental health. We have proprietary and differentiated methods for manufacturing, formulating, dosing and administering psychedelic compounds. We have the right scientific and executive team to successfully deliver new therapies to patients.We are addressing indications with critical, unmet medical needs that most psychedelic drug development companies are not.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tryp TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8910 University Center Lane Suite 400 San Diego, CA 92122
    Telephone
    Telephone
    1-833-811-TRYP
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://tryptherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tryp-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/tryptherapeutic

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tryp, Exopharm Announce Arrangement Completion
    Tryp, Exopharm Announce Arrangement Completion

    01 May 2024

    // ACCESSWIRE

    https://www.accesswire.com/858639/tryp-therapeutics-and-exopharm-limited-announce-completion-of-plan-of-arrangement

    ACCESSWIRE
    01 May 2024
    Share Share
    Tryp Updates Exopharm Arrangement, Halts Trading
    Tryp Updates Exopharm Arrangement, Halts Trading

    24 Apr 2024

    // ACCESSWIRE

    https://www.accesswire.com/855838/tryp-therapeutics-provides-update-on-plan-of-arrangement-with-exopharm-limited-and-announces-voluntary-trading-halt

    ACCESSWIRE
    24 Apr 2024
    Share Share
    Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor of Arrangement Agreement at Annual General and Special Meeting of Securityholders, and Receipt of Final Order
    Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor of Arrangement Agreement at Annual General and Special Meeting of Securityholders, and Receipt of Final Order

    12 Mar 2024

    // ACCESSWIRE

    https://www.accesswire.com/841924/tryp-therapeutics-announces-9992-votes-cast-by-shareholders-in-favor-of-arrangement-agreement-at-annual-general-and-special-meeting-of-securityholders-and-receipt-of-final-order

    ACCESSWIRE
    12 Mar 2024
    Share Share
    Tryp Therapeutics and Exopharm Limited Secure Pivotal 2 Cent Waiver From ASX
    Tryp Therapeutics and Exopharm Limited Secure Pivotal 2 Cent Waiver From ASX

    26 Jan 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=828328&lang=en

    ACCESSWIRE
    26 Jan 2024
    Share Share
    Tryp Announces Significant Milestone in Its Clinical Trial Program for Trp-8803
    Tryp Announces Significant Milestone in Its Clinical Trial Program for Trp-8803

    08 Jan 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=822642&lang=en

    ACCESSWIRE
    08 Jan 2024
    Share Share
    Tryp Announces First Patient Dosed in Phase 2a for the Treatment of Fibromyalgia
    Tryp Announces First Patient Dosed in Phase 2a for the Treatment of Fibromyalgia

    04 Jan 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=821703&lang=en

    ACCESSWIRE
    04 Jan 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search